Skip to content

H2020

TransQST

Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030

Programme
Horizon 2020
Started
Ends
Duration
68 months
Total cost
EUR 18,132,874
EU contribution
EUR 8,000,000
Participants
24 from 9 countries
Topic
H2020_IMI2-2015-06-01
Grant agreement
116030

Coordinated by The University of Liverpool (GBUnited Kingdom).

Consortium

EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.

Members of the consortium, coordinator first
OrganisationCountryRoleEU contributionRecognised by
The University of LiverpoolGBUnited KingdomCoordinatorEUR 1,161,914PIC (1.00)
Universitat WienATAustriaParticipantEUR 350,250known name (0.95)
Janssen Pharmaceutica NVBEBelgiumParticipantEUR 0PIC (1.00)
Abbvie Deutschland GmbH & Co KGDEGermanyParticipantEUR 0PIC (1.00)
Boehringer Ingelheim InternationalgmbhDEGermanyParticipantEUR 0PIC (1.00)
European Molecular Biology LaboratoryDEGermanyParticipantEUR 1,093,089PIC (1.00)
Forschungsgesellschaft Fur Arbeitsphysiologie und Arbeitsschutz EvDEGermanyParticipantEUR 350,250known name (0.97)
Universitaetsklinikum AachenDEGermanyParticipantEUR 132,435PIC (1.00)
Universitatsklinikum HeidelbergDEGermanyParticipantEUR 269,790known name (0.97)
Fundacio Institut Hospital del Mar D Investigacions MediquesESSpainParticipantEUR 900,525known name (0.97)
Synapse Research Management Partners SLESSpainParticipantEUR 353,669PIC (1.00)
Orion OYJFIFinlandParticipantEUR 0PIC (1.00)
Institut de Recherches Internationales ServierFRFranceParticipantEUR 0PIC (1.00)
Sanofi-Aventis Recherche & DeveloppementFRFranceParticipantEUR 0PIC (1.00)
Certara UK LimitedGBUnited KingdomParticipantEUR 484,600PIC (1.00)
Eli Lilly and Company LtdGBUnited KingdomParticipantEUR 0PIC (1.00)
Glaxosmithkline Research & Development LimitedGBUnited KingdomParticipantEUR 0PIC (1.00)
The Chancellor, Masters and Scholars of the University of OxfordGBUnited KingdomParticipantEUR 325,000PIC (1.00)
Vertex Pharmaceuticals (Europe) LimitedGBUnited KingdomParticipantEUR 0PIC (1.00)
Crown Bioscience Netherlands BVNLNetherlandsParticipantEUR 325,354PIC (1.00)
Erasmus Universitair Medisch Centrum RotterdamNLNetherlandsParticipantEUR 220,500PIC (1.00)
Universiteit LeidenNLNetherlandsParticipantEUR 1,239,324known name (0.95)
Universiteit MaastrichtNLNetherlandsParticipantEUR 793,300known name (0.95)
Astrazeneca ABSESwedenParticipantEUR 0PIC (1.00)

Changes of the consortium

First seen on with 24 participants from 9 countries.

A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.

Project page on CORDIS (opens in new tab)

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.